BioSpace News Archive

Danaher Corporation announced results for the third quarter ended September 29, 2023.

Annexon, Inc. announced that the European Medicines Agency has granted Priority Medicine designation to ANX007 for the treatment of geographic atrophy secondary to age-related macular degeneration.

MeMed is pleased to announce that it has been awarded a contract valued at $727,799 by the Division of Research, Innovation, and Ventures of the U.S. Department of Health and Human Services, Biomedical Advanced Research and Development Authority.

Hyloris Pharmaceuticals SA, a specialty biopharma company committed to addressing unmet medical needs through reinventing existing medications, announces it has out-licensed its product candidate atomoxetine oral liquid for the treatment of attention deficit hyperactivity disorder in Canada to Kye Pharmaceuticals.

This week at CPHI Barcelona, Pharmatech Associates will showcase its expertise and capabilities that help global pharmaceutical and emerging biotech companies accelerate their innovation and speed delivery of breakthrough medicines and therapies to patients.

IRLAB Therapeutics AB, a company discovering and developing novel treatments for Parkinson’s disease, announced that the company will present at the BioStock Life Science Fall Summit on Thursday, October 26, 2023, in Lund.